טוען...
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...
שמור ב:
| הוצא לאור ב: | J Gynecol Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823988/ https://ncbi.nlm.nih.gov/pubmed/29468856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e32 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|